Ildong Holdings Co Ltd (000230) fair value: what the stock is really worth
As of Oct 19, 2026: fair value (intrinsic value) of Ildong Holdings Co Ltd stock KRW 18,210, price KRW 6,070, upside +200.0%, quality 42 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range 5,686 KRW – 50,723 KRW · fair‑value band 11,827 KRW – 26,667 KRW · the 6,070 KRW price screens below the 18,210 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Ildong Holdings Co in your weekly email
Every Wednesday you see whether Ildong Holdings Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.
Show moreShow less
It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product.
It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics.
In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online; and manufactures original and generic prescription drugs.
Further, it offers probiotics; pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions; and engages in advertising business.
The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is headquartered in Seoul, South Korea.
Stock analysis
Ildong Holdings Co Ltd (000230) currently trades at 6,070 KRW, while our model-based Fair Value estimate is 18,210 KRW, implying the stock looks roughly 66.7% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 22,106 KRW per share, and 20 of the 26 models we run sit above the 6,070 KRW price.
Bear case: the Asset-Based group reads lowest at 5,220 KRW, and 6 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 11,827 KRW (bear) to 26,667 KRW (bull), the price of 6,070 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Ildong Holdings Co Ltd reported revenue of 591B KRW in FY2025 versus 592B KRW in FY2021, a compound −0.1%/yr. Reported net income was 10.9B KRW in FY2025.
Key figures
Market cap 68.5B KRW (≈ $51.5M) Micro · P/S ratio 0.12 · Dividend yield 1.6% · Net margin 3.6% · Return on equity 13.8% · Return on assets (EBIT) −5.6% · Operating margin 2.3% · Revenue (TTM) 608B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 31 out of 100 (low confidence).
What moves the price
The share trades about 61% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −24% fair-value upside, at 200%, 000230 screens cheaper than that median.
Fair Value models
Bear11,827 KRWFair Value 18,210 KRWBull26,667 KRW
Price 6,070 KRW · Upside +200.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−6.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.2%
Start year 2020 (pandemic). Over 10 years: +31.5% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.5% (2020) → 2.6% (2025)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+14.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +12.5% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 577 stocks
Beats the industry median on 8/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside+200.0% · Top 25%
Profitability
Return on equity (12 months)13.8% · Top 25%
Return on assets1.4% · Below median
Net margin (12 months)3.6% · Below median
Operating margin (12 months)2.3% · Below median
Growth and dividend
Revenue growth (quarter YoY)6.2% · Above median
Dividend yield (12 months)1.6% · Above median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Ildong Holdings Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/000230
Frequently asked questions
Is Ildong Holdings Co Ltd (000230) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 18,210 KRW versus a price of 6,070 KRW, about +200% upside (undervalued).
What is the fair value of 000230?
Our model-based fair value for Ildong Holdings Co Ltd is 18,210 KRW (as of Oct 3, 2026), built from audited fundamentals. The current price: 6,070 KRW.
What is the quality score of 000230?
Ildong Holdings Co Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ildong Holdings Co Ltd (000230)?
Our model-based price target is the fair value of 18,210 KRW (as of Oct 3, 2026) from 26 valuation models. Cautious scenario 11,827 KRW, optimistic scenario 26,667 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Ildong Holdings Co Ltd stock forecast for 2026?
Our models put fair value at 18,210 KRW, about +200% upside versus a price of 6,070 KRW (undervalued). Cautious scenario 11,827 KRW, optimistic scenario 26,667 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Ildong Holdings Co Ltd (000230)?
Ildong Holdings Co Ltd reported trailing-twelve-month revenue of about 608B KRW (latest available figure, as of Oct 3, 2026).
Does Ildong Holdings Co Ltd pay a dividend?
Ildong Holdings Co Ltd currently shows a dividend yield of 1.65% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Ildong Holdings Co Ltd (000230)?
For today's price to be fair in a discounted-cash-flow model, Ildong Holdings Co Ltd would have to grow free cash flow by +14.9 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.2 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of 000230 use?
Our models discount Ildong Holdings Co Ltd at 11.6 %: a base by market capitalisation (micro), damped by beta 0.19, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Ildong Holdings Co Ltd that is +14.9 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Ildong Holdings Co Ltd (000230) delivered so far?
Over the past 5 years revenue at Ildong Holdings Co Ltd grew -0.2 % a year. The price currently implies +14.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Ildong Holdings Co Ltd (000230) growing?
The median revenue growth in the sector is +5.6 % a year. That is the yardstick for the growth priced into Ildong Holdings Co Ltd (+14.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Ildong Holdings Co Ltd (000230)?
The free-cash-flow yield on the price is 13.09 %: that much free cash flow Ildong Holdings Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Ildong Holdings Co Ltd (000230)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ildong Holdings Co Ltd it is 18,210 KRW per share (as of Oct 3, 2026), against a price of 6,070 KRW. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Ildong Holdings Co Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 000230 trades below its calculated fair value: price 6,070 KRW, fair value 18,210 KRW, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 000230?
No. The price is what the market pays today (6,070 KRW); the fair value is what the company's own numbers justify (18,210 KRW). For Ildong Holdings Co Ltd the two are 12,140 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Ildong Holdings Co Ltd worth?
The market values Ildong Holdings Co Ltd at about 68.5B KRW (market capitalisation, as of Oct 3, 2026). Per share that is 6,070 KRW; our models calculate a fair value of 18,210 KRW per share.
What do the bullish and bearish scenarios say about 000230?
Our models span a range for Ildong Holdings Co Ltd: cautious scenario 11,827 KRW, base 18,210 KRW, optimistic 26,667 KRW per share (as of Oct 3, 2026, price 6,070 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Ildong Holdings Co Ltd (000230)?
Balance-sheet figures for Ildong Holdings Co Ltd (as of Oct 3, 2026): return on equity 13.8%, debt of 0.02 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 000230 from its 52-week high?
Ildong Holdings Co Ltd trades at 6,070 KRW, about 61% below its 52-week high of 15,660 KRW and 6% above the low of 5,710 KRW (as of Oct 19, 2026). Distance from the high says nothing about value: that is what the fair value of 18,210 KRW is for.
Which stocks are comparable to Ildong Holdings Co Ltd?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ildong Holdings Co Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price 6,070 KRW, calculated fair value 18,210 KRW (+200%), Quality Score 42/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 000230 calculated?
We run Ildong Holdings Co Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 18,210 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Ildong Holdings Co Ltd currently trades 67 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ildong Holdings Co Ltd (000230)?
The closing price on Oct 19, 2026 was 6,070 KRW. Our model-based fair value is 18,210 KRW, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ildong Holdings Co Ltd right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (11,827 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (11,827 KRW to 26,667 KRW) leaves room in how you read the outcome.
Key figures of Ildong Holdings Co Ltd
How large is the market capitalisation of Ildong Holdings Co Ltd (000230)?
The market capitalisation of Ildong Holdings Co Ltd is 68.5B KRW (≈ $51.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Ildong Holdings Co Ltd (000230)?
The price-to-sales ratio of Ildong Holdings Co Ltd is 0.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Ildong Holdings Co Ltd (000230)?
The dividend yield of Ildong Holdings Co Ltd is 1.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Ildong Holdings Co Ltd (000230)?
The net margin of Ildong Holdings Co Ltd is 3.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Ildong Holdings Co Ltd (000230)?
The return on equity (ROE) of Ildong Holdings Co Ltd is 13.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Ildong Holdings Co Ltd (000230)?
On an EBIT basis the return on assets of Ildong Holdings Co Ltd is −5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ildong Holdings Co Ltd (000230)?
The operating margin of Ildong Holdings Co Ltd is 2.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Ildong Holdings Co Ltd (000230)?
Revenue at Ildong Holdings Co Ltd is growing +6.2% versus a year earlier (3y avg −4.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Ildong Holdings Co Ltd (000230)?
Earnings per share at Ildong Holdings Co Ltd are growing −62.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Ildong Holdings Co Ltd (000230) carry?
The net debt of Ildong Holdings Co Ltd is 117B KRW (fiscal year 2025, ≈ 13.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Ildong Holdings Co Ltd in the live analysis
One click puts Ildong Holdings Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 3, 2026